Comparison of combinations of drugs for treatment of obesity: body weight and echocardiographic status. (Q36673903)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17146452%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

title

Comparison of combinations of drugs for treatment of obesity: body weight and echocardiographic status (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17146452%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17146452%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

author name string

Dhurandhar NV

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17146452%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Rahko PS

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17146452%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Atkinson RL

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17146452%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

language of work or name

English

0 references

publication date

5 December 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17146452%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Obesity

22 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17146452%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17146452%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17146452%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

page(s)

850-857

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17146452%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.ijo.0803498

22 December 2019

exact match

0 references

cites work

Long-term weight control: the National Heart, Lung, and Blood Institute funded multimodal intervention study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803498

The fen-phen finale: a study of weight loss and valvular heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803498

Beneficial effects of pharmacotherapy on weight loss, depressive symptoms, and eating patterns in obese binge eaters and non-binge eaters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803498

Lower dosages of phentermine-fenfluramine given in the afternoon: five cases with significant weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803498

The relationship between health-related quality of life and weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803498

Pharmaceutical cost savings of treating obesity with weight loss medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803498

International trial of long-term dexfenfluramine in obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803498

Dexfenfluramine in the treatment of severe obesity: a placebo-controlled investigation of the effects on weight loss, cardiovascular risk factors, food intake and eating behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803498

Sibutramine: a novel new agent for obesity treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803498

Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803498

Valvular heart disease associated with fenfluramine-phentermine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803498

Further cases of valvular heart disease associated with fenfluramine-phentermine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803498

An assessment of heart-valve abnormalities in obese patients taking dexfenfluramine, sustained-release dexfenfluramine, or placebo. Sustained-Release Dexfenfluramine Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803498

Asymptomatic mitral and aortic valve disease is seen in half of the patients taking 'phen-fen'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803498

The prevalence of cardiac valvular insufficiency assessed by transthoracic echocardiography in obese patients treated with appetite-suppressant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803498

Risk for valvular heart disease among users of fenfluramine and dexfenfluramine who underwent echocardiography before use of medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803498

Serial echocardiographic and clinical evaluation of valvular regurgitation before, during, and after treatment with fenfluramine or dexfenfluramine and mazindol or phentermine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803498

Dose-effect of fenfluramine use on the severity of valvular heart disease among fen-phen patients with valvulopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803498

Echocardiographic prevalence of mitral and/or aortic regurgitation in patients exposed to either fenfluramine-phentermine combination or to dexfenfluramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803498

A population-based study of appetite-suppressant drugs and the risk of cardiac-valve regurgitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803498

Open treatment of overweight binge eaters with phentermine and fluoxetine as an adjunct to cognitive-behavioral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803498

The "phen-pro" diet drug combination is not associated with valvular heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803498

Fluoxetine: a randomized clinical trial in the maintenance of weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803498

Efficacy and safety of long-term fluoxetine treatment of obesity--maximizing success

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803498

Effects of Nefazodone on Body Weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803498

Benefits of lifestyle modification in the pharmacologic treatment of obesity: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803498

Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803498

Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803498

Drug treatment of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803498

7 January 2021

Long-term drug treatment of obesity in a private practice setting

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803498

7 January 2021

Initial weight loss as a predictor of response to obesity drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803498

7 January 2021

A double-blind randomized placebo-controlled trial of sibutramine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803498

7 January 2021

Valvular heart disease associated with fenfluramine-phentermine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803498

7 January 2021

Low prevalence of valvular heart disease in 226 phentermine-fenfluramine protocol subjects prospectively followed for up to 30 months

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803498

7 January 2021

Comparison of either norepinephrine-uptake inhibitors or phentermine combined with serotonergic agents on food intake in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803498

7 January 2021

A toxic reaction from combining fluoxetine and phentermine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803498

7 January 2021

Effects of sibutramine plus orlistat in obese women following 1 year of treatment by sibutramine alone: a placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803498

7 January 2021

Predictors of weight loss and maintenance during 2 years of treatment by sibutramine in obesity. Results from the European multi-centre STORM trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803498

7 January 2021

What is a reasonable weight loss? Patients' expectations and evaluations of obesity treatment outcomes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803498

7 January 2021

Anorexigens and pulmonary hypertension in the United States: results from the surveillance of North American pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803498

7 January 2021

Characterization of phentermine and related compounds as monoamine oxidase (MAO) inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803498

7 January 2021

Identifiers

DOI

10.1038/SJ.IJO.0803498

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17146452%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

1 reference